Nutex Health (US:NUTX) Prnewswireยท2025-08-14 21:10Core Viewpoint - Nutex Health Inc. announced a delay in filing its Form 10-Q for the period ending June 30, 2025, due to non-cash accounting adjustments related to stock-based compensation obligations for certain hospitals under construction [1][2]. The company also revealed preliminary financial results and initiated a stock repurchase program of up to $25 million [1][7]. Financial Highlights - For the three months ended June 30, 2025, total revenue was $244.0 million, a 220.7% increase from $76.1 million in the same period of 2024. Revenue from mature hospitals increased by 203.2% [8]. - Gross profit for the same period was $124.9 million, representing 51.2% of total revenue, compared to $22.6 million or 29.7% in 2024 [8]. - Total visits at the Hospital Division were 45,573, an increase of 10.6% from 41,208 in the same period of 2024 [8]. - For the six months ended June 30, 2025, total revenue was $455.8 million, up 217.5% from $143.5 million in 2024. Revenue from mature hospitals increased by 195.2% [8]. - Gross profit for the six months was $243.3 million, or 53.4% of total revenue, compared to $32.7 million or 22.8% in 2024 [8]. - Total visits for the six months were 93,842, a 15.5% increase from 81,276 in the same period of 2024 [8]. Stock Repurchase Program - The Board of Directors authorized a stock repurchase program of up to $25.0 million to commence upon filing of the Form 10-Q for the period ended June 30, 2025. The aim is to enhance shareholder value and offset dilution from future stock compensation obligations [7][10].